1832 Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

1832 Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-270	Closed	-$30K	–	719
2019 Q1	$30K	Sell	270 -21,930	-99%	-$2.41M	﹤0.01%	531
2018 Q4	$2.14M	Sell	22,200 -1,500	-6%	-$159K	0.01%	337
2018 Q3	$2.89M	Sell	23,700 -1,900	-7%	-$224K	0.01%	339
2018 Q2	$2.81M	Sell	25,600 -17,100	-40%	-$1.83M	0.01%	349
2018 Q1	$4.58M	Buy	42,700 +100	+0.2%	+$11.1K	0.02%	297
2017 Q4	$4.53M	Sell	42,600 -9,600	-18%	-$1.03M	0.01%	296
2017 Q3	$5.63M	Buy	52,200 +7,200	+16%	+$770K	0.02%	285
2017 Q2	$4.66M	Sell	45,000 -3,945	-8%	-$389K	0.02%	315
2017 Q1	$4.79M	Buy	48,945 +5,445	+13%	+$521K	0.02%	324
2016 Q4	$3.85M	Sell	43,500 -1,500	-3%	-$137K	0.01%	358
2016 Q3	$4.34M	Buy	45,000 +2,100	+5%	+$200K	0.02%	326
2016 Q2	$3.7M	Buy	+42,900	New	+$3.85M	0.01%	323
2015 Q4	–	Sell	-357	Closed	-$36K	–	680
2015 Q3	$36K	Hold	357	–	–	﹤0.01%	509
2015 Q2	$44K	Buy	+357	New	+$42.7K	﹤0.01%	536
2014 Q1	–	Sell	-32,400	Closed	-$2.46M	–	624
2013 Q4	$2.46M	Buy	32,400 +23,925	+282%	+$1.7M	0.01%	352
2013 Q3	$588K	Sell	8,475 -53,325	-86%	-$3.49M	﹤0.01%	350
2013 Q2	$3.58M	Buy	+61,800	New	+$3.57M	0.02%	297

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

1832 Asset Management's IBB Position: Q2 2019 in Review

1832 Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 270 shares — an estimated $30K sold.

1832 Asset Management first reported a position in IBB in Q2 2013 and held it in 17 quarters. The position peaked at $5.63M in Q3 2017. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

1832 Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
1832 Asset Management sold 270 iShares Biotechnology ETF shares in Q2 2019, an estimated $30K.
1832 Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 17 quarters.
1832 Asset Management's iShares Biotechnology ETF position peaked at $5.63M in Q3 2017.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on 1832 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.